Results 181 to 190 of about 999,769 (295)

Unusual Giant Sialocyst Arising From Wharton's Duct: A Case Report

Oral Surgery, EarlyView.
ABSTRACT Background Head and neck masses in adults are a common reason for referral to maxillofacial surgeons and otolaryngologists, and most are benign. True salivary duct cysts (sialocysts) are extremely rare, accounting for < 1% of salivary duct lesions, and primarily involve minor salivary glands. Involvement of major salivary glands is exceptional,
Maksym Skrypnyk, Margarita Skikevych, Roman Skrypnyk, Volodymyr Mykytenko, Igor Skrypnyk, Liudmyla Voloshyna, Tetiana Yatsenko, Chun Xu, Satoshi Takahashi, Taro Osada, Koichi Hattori, Beate Heissig   +11 more
wiley   +1 more source

Immunosenescence in Idiopathic Pulmonary Fibrosis. [PDF]

J Inflamm Res
Xiao S, Li Z, Zhang H, Cai W, Yu S, Song X.   +5 more
europepmc   +1 more source

From senescence and inflammaging to systemic comorbidities: Drivers of aging‐associated periodontitis

Periodontology 2000, EarlyView.
Abstract Background Aging is accompanied by a chronic low‐grade inflammatory process, known as inflammaging, as well as immunosenescence, an age‐related decline and dysregulation of immune function, and cellular senescence, a process in which cells enter a state of irreversible growth arrest while actively releasing pro‐inflammatory factors.
James Cheng, Chew Tin Zar Aung, Samuel F. Suslavich, Sinem Esra Sahingur, Yvonne L. Hernandez‐Kapila   +4 more
wiley   +1 more source

Clonal hematopoiesis is associated with progression of idiopathic pulmonary fibrosis. [PDF]

JCI Insight
Asarian L, Jia J, Sirokha D, Paulini L, Dietel D, Stoleriu MG, Frankenberger M, Yildirim AÖ, Götze KS, Behr J, Hunninghake GM, Fernandez IE.   +11 more
europepmc   +1 more source

Idiopathic pulmonary fibrosis: current treatment options and critical appraisal of nintedanib

, 2015
Francesco Bonella,1 Susanne Stowasser,2 Lutz Wollin3 1Interstitial and Rare Lung Disease Unit, Ruhrlandklinik, University Hospital, University of Duisburg-Essen, Essen, 2Boehringer Ingelheim Pharma GmbH & Co.
Bonella F, Wollin L, Stowasser S
core  

Impact of Letermovir on Voriconazole Concentrations in Lung Transplant Patients

Transplant Infectious Disease, EarlyView.
Concomitant letermovir was associated with lower voriconazole exposure and reduced attainment of commonly used efficacy thresholds in lung transplant recipients. Routine therapeutic drug monitoring after letermovir initiation is recommended, and empiric voriconazole dose escalation may be needed to avoid subtherapeutic exposure. ABSTRACT Background The
Leah Georgiades, Sunish Shah, Erin K. McCreary, Fernanda Silveira, Raman Venkataramanan, Vignesh Vasudevan, Ryan M. Rivosecchi   +6 more
wiley   +1 more source

Vascular and skeletal muscle oxidative capacity responses to continuous double and single leg cycling

Experimental Physiology, EarlyView.
Abstract The purpose of this work was to determine endothelial, microvascular, skeletal muscle oxidative capacity (SMOC) and cardiorespiratory responses to an acute bout of continuous single leg cycling (SLC) and double leg cycling (DLC). Ten recreationally active men and women volunteered to participate in this investigation and reported to the ...
Edward Z. Pelka, B. Ryan Davis, John McDaniel   +2 more
wiley   +1 more source

Idiopathic Pulmonary Fibrosis update, comparing the Australasian Interstitial Lung Disease Registry to the Australian Idiopathic Pulmonary Fibrosis Registry. [PDF]

Intern Med J
Chee M, Khor YH, Jackson D, Cooper W, D'Costa J, de Boer S, Edwards A, Ellis S, Gabbay E, Gallagher H, Glaspole I, Goh N, Grainge C, Hopkins P, Keir G, Kwan B, Mackintosh J, Moodley Y, Moore I, Navaratnam V, Ong C, Reynolds P, Royals K, Teoh A, Troy L, Veitch E, Wilsher M, Wrobel J, Zappala C, Corte T, Thien F, AILDR Steering Committee.   +31 more
europepmc   +1 more source

Systemic pirfenidone treatment fails to mitigate fibrosis and compromises functional recovery in a porcine model of volumetric muscle loss

Experimental Physiology, EarlyView.
Abstract Repurposing clinically approved antifibrotic agents presents a potential near‐term therapeutic strategy to mitigate the extensive fibrotic scarring that follows severe volumetric muscle loss (VML) injury and inhibits functional recovery. We hypothesized that daily oral administration of pirfenidone, an FDA‐approved antifibrotic, would mitigate
Jessica M. Motherwell, Ondine Eken, Claudia E. Hernandez, Christopher L. Dearth, Stephen M. Goldman   +4 more
wiley   +1 more source

Somatic mutation analysis of mucin genes and pathways in idiopathic pulmonary fibrosis. [PDF]

Am J Respir Crit Care Med
Seo MK, Blumhagen R, Cho MH, Schwartz DA, Yun JH.   +4 more
europepmc   +1 more source